nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—PTGS2—Risedronate—osteoporosis	0.418	0.43	CbGbCtD
Lumiracoxib—CYP1A2—Estropipate—osteoporosis	0.119	0.123	CbGbCtD
Lumiracoxib—CYP2C9—Estropipate—osteoporosis	0.108	0.111	CbGbCtD
Lumiracoxib—CYP2C19—Cholecalciferol—osteoporosis	0.0666	0.0686	CbGbCtD
Lumiracoxib—CYP1A2—Conjugated Estrogens—osteoporosis	0.0565	0.0582	CbGbCtD
Lumiracoxib—CYP2C9—Cholecalciferol—osteoporosis	0.0554	0.0571	CbGbCtD
Lumiracoxib—CYP2C19—Estradiol—osteoporosis	0.0537	0.0553	CbGbCtD
Lumiracoxib—CYP1A2—Estradiol—osteoporosis	0.0496	0.0511	CbGbCtD
Lumiracoxib—CYP2C9—Estradiol—osteoporosis	0.0447	0.046	CbGbCtD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	8.6e-05	0.00295	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	8.24e-05	0.00283	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PKM—osteoporosis	8.24e-05	0.00283	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—FDPS—osteoporosis	8.24e-05	0.00283	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoporosis	8.18e-05	0.00281	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	7.93e-05	0.00272	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PGLS—osteoporosis	7.81e-05	0.00268	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GPD2—osteoporosis	7.81e-05	0.00268	CbGpPWpGaD
Lumiracoxib—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	7.73e-05	0.00265	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	7.51e-05	0.00258	CbGpPWpGaD
Lumiracoxib—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	7.43e-05	0.00255	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	7.36e-05	0.00253	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IL1B—osteoporosis	7.17e-05	0.00246	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PNP—osteoporosis	7.14e-05	0.00245	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ATIC—osteoporosis	7.14e-05	0.00245	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—POMC—osteoporosis	7.12e-05	0.00244	CbGpPWpGaD
Lumiracoxib—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	7.05e-05	0.00242	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	6.87e-05	0.00236	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	6.83e-05	0.00234	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	6.82e-05	0.00234	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	6.77e-05	0.00232	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	6.74e-05	0.00231	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PKM—osteoporosis	6.71e-05	0.0023	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—FDPS—osteoporosis	6.71e-05	0.0023	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—TNF—osteoporosis	6.55e-05	0.00225	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	6.42e-05	0.0022	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	6.41e-05	0.0022	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PGLS—osteoporosis	6.37e-05	0.00218	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GPD2—osteoporosis	6.37e-05	0.00218	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PKM—osteoporosis	6.37e-05	0.00218	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—SOST—osteoporosis	6.37e-05	0.00218	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	6.25e-05	0.00214	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	6.23e-05	0.00214	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	6.14e-05	0.00211	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CA2—osteoporosis	6.07e-05	0.00208	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—OXCT1—osteoporosis	6.07e-05	0.00208	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PGLS—osteoporosis	6.03e-05	0.00207	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ANTXR2—osteoporosis	6.03e-05	0.00207	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.02e-05	0.00207	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—MGLL—osteoporosis	5.92e-05	0.00203	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5.85e-05	0.00201	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	5.84e-05	0.002	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ATIC—osteoporosis	5.82e-05	0.002	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PNP—osteoporosis	5.82e-05	0.002	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	5.8e-05	0.00199	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	5.78e-05	0.00198	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—TGFB1—osteoporosis	5.74e-05	0.00197	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	5.69e-05	0.00195	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	5.67e-05	0.00194	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.58e-05	0.00191	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PKM—osteoporosis	5.33e-05	0.00183	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—FDPS—osteoporosis	5.33e-05	0.00183	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	5.32e-05	0.00183	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	5.31e-05	0.00182	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	5.3e-05	0.00182	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	5.29e-05	0.00181	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	5.25e-05	0.0018	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	5.2e-05	0.00178	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—GSN—osteoporosis	5.13e-05	0.00176	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PGLS—osteoporosis	5.05e-05	0.00173	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GPD2—osteoporosis	5.05e-05	0.00173	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—IDH2—osteoporosis	5.03e-05	0.00173	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	5e-05	0.00172	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.99e-05	0.00171	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.99e-05	0.00171	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—OXCT1—osteoporosis	4.95e-05	0.0017	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CA2—osteoporosis	4.95e-05	0.0017	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	4.95e-05	0.0017	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	4.95e-05	0.0017	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	4.87e-05	0.00167	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—MGLL—osteoporosis	4.82e-05	0.00165	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CYP27A1—osteoporosis	4.73e-05	0.00162	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PNP—osteoporosis	4.62e-05	0.00159	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ATIC—osteoporosis	4.62e-05	0.00159	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ACP5—osteoporosis	4.6e-05	0.00158	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.55e-05	0.00156	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.55e-05	0.00156	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.54e-05	0.00156	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—LRP5—osteoporosis	4.46e-05	0.00153	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—MYC—osteoporosis	4.42e-05	0.00152	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	4.41e-05	0.00151	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—TPI1—osteoporosis	4.28e-05	0.00147	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—LRP6—osteoporosis	4.27e-05	0.00146	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.25e-05	0.00146	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	4.2e-05	0.00144	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TNF—osteoporosis	4.11e-05	0.00141	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—POMC—osteoporosis	4.1e-05	0.00141	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—IDH2—osteoporosis	4.1e-05	0.00141	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—RPL24—osteoporosis	4.1e-05	0.00141	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—LTF—osteoporosis	4.1e-05	0.00141	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—P4HB—osteoporosis	4.02e-05	0.00138	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GAPDH—osteoporosis	3.95e-05	0.00135	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—OXCT1—osteoporosis	3.93e-05	0.00135	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CA2—osteoporosis	3.93e-05	0.00135	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.89e-05	0.00133	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—FDPS—osteoporosis	3.87e-05	0.00133	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PKM—osteoporosis	3.87e-05	0.00133	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.87e-05	0.00133	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CYP27A1—osteoporosis	3.86e-05	0.00132	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—RAP1A—osteoporosis	3.85e-05	0.00132	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—MGLL—osteoporosis	3.83e-05	0.00131	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ACP5—osteoporosis	3.75e-05	0.00129	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—POMC—osteoporosis	3.74e-05	0.00128	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.7e-05	0.00127	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GPD2—osteoporosis	3.67e-05	0.00126	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PGLS—osteoporosis	3.67e-05	0.00126	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.61e-05	0.00124	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ACP5—osteoporosis	3.56e-05	0.00122	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PKM—osteoporosis	3.53e-05	0.00121	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—FDPS—osteoporosis	3.53e-05	0.00121	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—TPI1—osteoporosis	3.49e-05	0.0012	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ATIC—osteoporosis	3.36e-05	0.00115	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PNP—osteoporosis	3.36e-05	0.00115	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.35e-05	0.00115	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GPD2—osteoporosis	3.35e-05	0.00115	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PGLS—osteoporosis	3.35e-05	0.00115	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL6—osteoporosis	3.32e-05	0.00114	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.31e-05	0.00113	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TPI1—osteoporosis	3.31e-05	0.00113	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—P4HB—osteoporosis	3.28e-05	0.00112	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—IDH2—osteoporosis	3.26e-05	0.00112	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GAPDH—osteoporosis	3.22e-05	0.0011	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—POMC—osteoporosis	3.2e-05	0.0011	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—RAP1A—osteoporosis	3.14e-05	0.00108	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ENO1—osteoporosis	3.11e-05	0.00107	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—P4HB—osteoporosis	3.11e-05	0.00107	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PSMA2—osteoporosis	3.06e-05	0.00105	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PSMA5—osteoporosis	3.06e-05	0.00105	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CYP27A1—osteoporosis	3.06e-05	0.00105	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ATIC—osteoporosis	3.06e-05	0.00105	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PNP—osteoporosis	3.06e-05	0.00105	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—GAPDH—osteoporosis	3.05e-05	0.00105	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—FDPS—osteoporosis	3.02e-05	0.00103	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PKM—osteoporosis	3.02e-05	0.00103	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	3e-05	0.00103	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	3e-05	0.00103	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ACP5—osteoporosis	2.98e-05	0.00102	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.94e-05	0.00101	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NFATC1—osteoporosis	2.9e-05	0.000995	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—DKK1—osteoporosis	2.88e-05	0.000987	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PGLS—osteoporosis	2.86e-05	0.000981	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GPD2—osteoporosis	2.86e-05	0.000981	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CA2—osteoporosis	2.85e-05	0.000979	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—OXCT1—osteoporosis	2.85e-05	0.000979	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.8e-05	0.00096	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—MGLL—osteoporosis	2.78e-05	0.000954	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—WNT1—osteoporosis	2.77e-05	0.00095	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—TPI1—osteoporosis	2.77e-05	0.00095	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.73e-05	0.000938	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—FGA—osteoporosis	2.7e-05	0.000925	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.62e-05	0.0009	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PNP—osteoporosis	2.62e-05	0.000897	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ATIC—osteoporosis	2.62e-05	0.000897	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—P4HB—osteoporosis	2.6e-05	0.000893	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—OXCT1—osteoporosis	2.6e-05	0.000893	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CA2—osteoporosis	2.6e-05	0.000893	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GAPDH—osteoporosis	2.56e-05	0.000877	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—MGLL—osteoporosis	2.54e-05	0.00087	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ENO1—osteoporosis	2.53e-05	0.000869	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PSMA2—osteoporosis	2.5e-05	0.000857	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PSMA5—osteoporosis	2.5e-05	0.000857	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—RAP1A—osteoporosis	2.49e-05	0.000854	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CYP19A1—osteoporosis	2.49e-05	0.000853	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ENO1—osteoporosis	2.4e-05	0.000824	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.39e-05	0.00082	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PSMA5—osteoporosis	2.37e-05	0.000812	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PSMA2—osteoporosis	2.37e-05	0.000812	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—IDH2—osteoporosis	2.37e-05	0.000811	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—OXCT1—osteoporosis	2.22e-05	0.000763	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CA2—osteoporosis	2.22e-05	0.000763	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP27A1—osteoporosis	2.22e-05	0.000763	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CALCA—osteoporosis	2.21e-05	0.000757	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.17e-05	0.000745	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—MGLL—osteoporosis	2.17e-05	0.000743	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ACP5—osteoporosis	2.16e-05	0.000742	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—IDH2—osteoporosis	2.16e-05	0.00074	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.14e-05	0.000733	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.04e-05	0.000701	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ADCY5—osteoporosis	2.03e-05	0.000697	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP27A1—osteoporosis	2.03e-05	0.000696	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CYP19A1—osteoporosis	2.03e-05	0.000695	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GPX1—osteoporosis	2.02e-05	0.000694	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ENO1—osteoporosis	2.01e-05	0.00069	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—TPI1—osteoporosis	2.01e-05	0.00069	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—KL—osteoporosis	2e-05	0.000687	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PSMA2—osteoporosis	1.98e-05	0.00068	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PSMA5—osteoporosis	1.98e-05	0.00068	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ACP5—osteoporosis	1.97e-05	0.000677	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.95e-05	0.000668	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—P4HB—osteoporosis	1.89e-05	0.000649	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—MTHFR—osteoporosis	1.87e-05	0.000641	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GAPDH—osteoporosis	1.86e-05	0.000637	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—IDH2—osteoporosis	1.84e-05	0.000632	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—TPI1—osteoporosis	1.83e-05	0.000629	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—RAP1A—osteoporosis	1.81e-05	0.00062	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.73e-05	0.000594	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—P4HB—osteoporosis	1.72e-05	0.000591	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GAPDH—osteoporosis	1.69e-05	0.00058	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ACP5—osteoporosis	1.69e-05	0.000578	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.66e-05	0.000571	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ADCY5—osteoporosis	1.66e-05	0.000568	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GPX1—osteoporosis	1.65e-05	0.000566	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—RAP1A—osteoporosis	1.65e-05	0.000565	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CYP19A1—osteoporosis	1.61e-05	0.000552	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.58e-05	0.000541	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ADCY5—osteoporosis	1.57e-05	0.000538	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—TPI1—osteoporosis	1.57e-05	0.000538	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—MTHFR—osteoporosis	1.52e-05	0.000522	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—POMC—osteoporosis	1.49e-05	0.000512	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—P4HB—osteoporosis	1.47e-05	0.000505	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ENO1—osteoporosis	1.46e-05	0.000501	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GAPDH—osteoporosis	1.45e-05	0.000496	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MTHFR—osteoporosis	1.44e-05	0.000495	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PSMA5—osteoporosis	1.44e-05	0.000494	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PSMA2—osteoporosis	1.44e-05	0.000494	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.44e-05	0.000493	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—RAP1A—osteoporosis	1.41e-05	0.000483	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IRS2—osteoporosis	1.37e-05	0.000471	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ENO1—osteoporosis	1.33e-05	0.000457	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ADCY5—osteoporosis	1.31e-05	0.000451	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PSMA2—osteoporosis	1.31e-05	0.00045	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PSMA5—osteoporosis	1.31e-05	0.00045	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GPX1—osteoporosis	1.31e-05	0.000449	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.23e-05	0.000421	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—POMC—osteoporosis	1.22e-05	0.000418	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—MTHFR—osteoporosis	1.21e-05	0.000415	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IRS1—osteoporosis	1.2e-05	0.000411	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.17e-05	0.000401	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ENO1—osteoporosis	1.14e-05	0.000391	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IL6R—osteoporosis	1.13e-05	0.000386	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PSMA5—osteoporosis	1.12e-05	0.000385	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PSMA2—osteoporosis	1.12e-05	0.000385	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.07e-05	0.000365	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—POMC—osteoporosis	9.67e-06	0.000332	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ADCY5—osteoporosis	9.54e-06	0.000327	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GPX1—osteoporosis	9.51e-06	0.000326	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP19A1—osteoporosis	9.1e-06	0.000312	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—MTHFR—osteoporosis	8.78e-06	0.000301	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ADCY5—osteoporosis	8.7e-06	0.000299	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GPX1—osteoporosis	8.67e-06	0.000297	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—MTHFR—osteoporosis	8e-06	0.000275	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ADCY5—osteoporosis	7.44e-06	0.000255	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GPX1—osteoporosis	7.41e-06	0.000254	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—POMC—osteoporosis	7.02e-06	0.000241	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—MTHFR—osteoporosis	6.84e-06	0.000235	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MYC—osteoporosis	6.67e-06	0.000229	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TGFB1—osteoporosis	6.66e-06	0.000228	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—POMC—osteoporosis	6.4e-06	0.00022	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—POMC—osteoporosis	5.47e-06	0.000188	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IL6—osteoporosis	5.02e-06	0.000172	CbGpPWpGaD
